Treatment with RBL was effective against recurrent CDI among high-risk patients when administered at home or in clinical settings.

Arakoda ® (tafenoquine) is now available in an 8-count bottle format, according to 60 Degrees Pharmaceuticals. Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of ...

Influenza- and ARI-associated hospitalization rates in adults were highest in those with underlying medical conditions, but the risk was mediated by influenza vaccination.

A Texas woman has died after using tap water in a sinus rinse, leading to a rare but often fatal brain infection.

For pediatric patients presenting to a hospital, caregiver concern for clinical deterioration is associated with critical illness.

US Health and Human Services Secretary RFK Jr has removed all 17 members of the expert panel that makes US vaccine recommendations.

A 7-day course of antibiotics was noninferior to a 14-day course of antibiotics among patients hospitalized with GN-BSIs.

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration later this month.

Cardiorespiratory effects of fine particulate matter, a wildfire emission that can spike for months after fire begins, can persist for months.